Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

By sjmartinez • April 23, 2024

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. Dermatol Ther (Heidelb). 2024 Apr 22. doi: 10.1007/s13555-024-01147-7. Epub ahead of print. PMID: 38647975.

Tags: Clinical outcomes, Dermatology, ixekizumab, long-term, patient-reported outcomes, psoriasis, Publications, Quality of Life, Scalp clearance

Educating Dermatologists for the Artificial Intelligence Era

Wongvibulsin S, Lee I. Educating Dermatologists for the Artificial Intelligence Era. Dermatol Clin. 2025 Oct;43(4):593-601. doi: 10.1016/j.det.2025.05.010. Epub 2025 Jul 14. PMID: 41093481.

Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung[...]

Still no evidence for an environmentally responsive epigenetic clock in an insect

Maleszka R, Cardoso-Junior CAM, Pellegrini M. Still no evidence for an environmentally responsive epigenetic clock in an insect. Proc Natl Acad Sci U S A.[...]